JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M414090200 on May 4, 2005

J. Biol. Chem., Vol. 280, Issue 26, 25048-25059, July 1, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/26/25048    most recent
M414090200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLaughlin, J. N.
Right arrow Articles by Hamm, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLaughlin, J. N.
Right arrow Articles by Hamm, H. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Functional Selectivity of G Protein Signaling by Agonist Peptides and Thrombin for the Protease-activated Receptor-1*

Joseph N. McLaughlin, Lixin Shen, Michael Holinstat, Joshua D. Brooks, Emmanuele DiBenedetto, and Heidi E. Hamm{ddagger}

From the Department of Pharmacology, Vanderbilt University Medical Center, Department of Mathematics and Center for Biomathematics, Vanderbilt University, Nashville, Tennessee 37232

Thrombin activates protease-activated receptor-1 (PAR-1) by cleavage of the amino terminus to unmask a tethered ligand. Although peptide analogs can activate PAR-1, we show that the functional responses mediated via PAR-1 differ between the agonists. Thrombin caused endothelial monolayer permeability and mobilized intracellular calcium with EC50 values of 0.1 and 1.7 nM, respectively. The opposite order of activation was observed for agonist peptide (SFLLRN-CONH2 or TFLLRNKPDK) activation. The addition of inactivated thrombin did not affect agonist peptide signaling, suggesting that the differences in activation mechanisms are intramolecular in origin. Although activation of PAR-1 or PAR-2 by agonist peptides induced calcium mobilization, only PAR-1 activation affected barrier function. Induced barrier permeability is likely to be G{alpha}12/13-mediated as chelation of G{alpha}q-mediated intracellular calcium with BAPTA-AM, pertussis toxin inhibition of G{alpha}i/o, or GM6001 inhibition of matrix metalloproteinase had no effect, whereas Y-27632 inhibition of the G{alpha}12/13-mediated Rho kinase abrogated the response. Similarly, calcium mobilization is G{alpha}q-mediated and independent of G{alpha}i/o and G{alpha}12/13 because pertussis toxin Y-27632 and had no effect, whereas U-73122 inhibition of phospholipase C-{beta} blocked the response. It is therefore likely that changes in permeability reflect G{alpha}12/13 activation, and changes in calcium reflect G{alpha}q activation, implying that the pharmacological differences between agonists are likely caused by the ability of the receptor to activate G{alpha}12/13 or G{alpha}q. This functional selectivity was characterized quantitatively by a mathematical model describing each step leading to Rho activation and/or calcium mobilization. This model provides an estimate that peptide activation alters receptor/G protein binding to favor G{alpha}q activation over G{alpha}12/13 by ~800-fold.


Received for publication, December 15, 2004 , and in revised form, April 22, 2005.

* This work was supported by National Institutes of Health Grant 5P01 HL60678 and 5R01 GM068953, Keck Futures Initiatives/NAKFI Sig05 (to H. E. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains a supplemental figure.

{ddagger} To whom correspondence should be addressed: Dept. of Pharmacology, Vanderbilt University Medical Center, 444 Robinson Research Bldg., 23rd Ave. South at Pierce, Nashville, TN 37232-6600. Tel.: 615-343-3533; Fax: 615-343-1084; E-mail: heidi.hamm{at}vanderbilt.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
C. T. Walsh, J. Radeff-Huang, R. Matteo, A. Hsiao, S. Subramaniam, D. Stupack, and J. H. Brown
Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61
FASEB J, November 1, 2008; 22(11): 4011 - 4021.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Chen, F. Lin, M. E. Shin, F. Wang, L. Shen, and H. E. Hamm
RACK1 Regulates Directional Cell Migration by Acting on G{beta}{gamma} at the Interface with Its Effectors PLC{beta} and PI3K{gamma}
Mol. Biol. Cell, September 1, 2008; 19(9): 3909 - 3922.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
C. T. Walsh, D. Stupack, and J. H. Brown
G Protein-Coupled Receptors Go Extracellular: RhoA Integrates the Integrins
Mol. Interv., August 1, 2008; 8(4): 165 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Li, T. Syrovets, S. Paskas, Y. Laumonnier, and T. Simmet
Mature Dendritic Cells Express Functional Thrombin Receptors Triggering Chemotaxis and CCL18/Pulmonary and Activation-Regulated Chemokine Induction
J. Immunol., July 15, 2008; 181(2): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
X. Deng, P. F. Mercer, C. J. Scotton, A. Gilchrist, and R. C. Chambers
Thrombin Induces Fibroblast CCL2/JE Production and Release via Coupling of PAR1 to G{alpha}q and Cooperation between ERK1/2 and Rho Kinase Signaling Pathways
Mol. Biol. Cell, June 1, 2008; 19(6): 2520 - 2533.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. A. Schuepbach, C. Feistritzer, L. F. Brass, and M. Riewald
Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin
Blood, March 1, 2008; 111(5): 2667 - 2673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Troyanovsky, D. F. Alvarez, J. A. King, and K. L. Schaphorst
Thrombin enhances the barrier function of rat microvascular endothelium in a PAR-1-dependent manner
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L266 - L275.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie
The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells
Blood, December 1, 2007; 110(12): 3909 - 3916.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S.-H. Hsu and C.-W. Luo
Molecular dissection of G protein preference using Gs{alpha} chimeras reveals novel ligand signaling of GPCRs
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1021 - E1029.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. S. Tutor, P. Penela, and F. Mayor Jr.
Anti-{beta}1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells
Cardiovasc Res, October 1, 2007; 76(1): 51 - 60.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. N. McLaughlin, M. M. Patterson, and A. B. Malik
Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization
PNAS, March 27, 2007; 104(13): 5662 - 5667.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Arora, T. K. Ricks, and J. Trejo
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer
J. Cell Sci., March 15, 2007; 120(6): 921 - 928.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Zhang, K. A. Kernan, S. J. Collins, X. Cai, J. M. Lopez-Guisa, J. L. Degen, Y. Shvil, and A. A. Eddy
Plasmin(ogen) Promotes Renal Interstitial Fibrosis by Promoting Epithelial-to-Mesenchymal Transition: Role of Plasmin-Activated Signals
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 846 - 859.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Simmons
Functional Selectivity of NK1 Receptor Signaling: Peptide Agonists Can Preferentially Produce Receptor Activation or Desensitization
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 907 - 913.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Galandrin and M. Bouvier
Distinct Signaling Profiles of beta1 and beta2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy
Mol. Pharmacol., November 1, 2006; 70(5): 1575 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Ramachandran, A. H. Morice, and S. J. Compton
Proteinase-Activated Receptor2 Agonists Upregulate Granulocyte Colony-Stimulating Factor, IL-8, and VCAM-1 Expression in Human Bronchial Fibroblasts
Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 133 - 141.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. H. Cleator, W. Q. Zhu, D. E. Vaughan, and H. E. Hamm
Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP
Blood, April 1, 2006; 107(7): 2736 - 2744.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Swift, A. J. Leger, J. Talavera, L. Zhang, A. Bohm, and A. Kuliopulos
Role of the PAR1 Receptor 8th Helix in Signaling: THE 7-8-1 RECEPTOR ACTIVATION MECHANISM
J. Biol. Chem., February 17, 2006; 281(7): 4109 - 4116.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. David-Dufilho, E. M.-V. Brussel, G. Topal, L. Walch, A. Brunet, and F. Rendu
Endothelial Thrombomodulin Induces Ca2+ Signals and Nitric Oxide Synthesis through Epidermal Growth Factor Receptor Kinase and Calmodulin Kinase II
J. Biol. Chem., October 28, 2005; 280(43): 35999 - 36006.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.